EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022–2023

Jacqueline Findlay, Otavio Hallal Ferreira Raro, Laurent Poirel, Patrice Nordmann, NARA Network

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04752-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Jacqueline Findlay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, CH-1700, Fribourg, Switzerland. Jacq…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Fribourg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The occurrence of metallo-beta-lactamase-producing Pseudomonas aeruginosa (MBL-PA) isolates is increasing globally, including in Switzerland. The aim of this study was to characterise, phenotypically and genotypically, the MBL-PA isolates submitted to the Swiss National Reference Center for Emerging Antibiotic Resistance (NARA) reference laboratory over a 12-month period from July 2022 to July 2023.

Methods

Thirty-nine non-duplicate MBL-PA Isolates were submitted to NARA over the study period from across Switzerland. Susceptibility was determined by broth microdilution according to EUCAST methodology. Whole-genome sequencing was performed on 34 isolates. Sequence types (STs) and resistance genes were ascertained using the Centre for Genomic Epidemiology platform. MBL genes, bla NDM-1 , bla IMP-1 , and bla VIM-2 , were cloned into vector pUCP24 and transformed into P. aeruginosa PA14.

Results

The most prevalent MBL types identified in this study were VIM (21/39; 53.8%) followed by NDM (11/39; 28.2%), IMP (6/39; 15.4%), and a single isolate produced both VIM and NDM enzymes. WGS identified 13 different STs types among the 39 isolates. They all exhibited resistance to cephalosporins, carbapenems, and the beta-lactam-beta-lactamase inhibitor combinations, ceftolozane-tazobactam, ceftazidime-avibactam, imipenem-relebactam, and meropenem-vaborbactam, and 8 isolates were cefiderocol (FDC) resistant. Recombinant P. aeruginosa strains producing bla NDM-1 , bla IMP-1 , and bla VIM-2 exhibited FDC MICs of 16, 8, and 1 mg/L, respectively.

Conclusions

This study showed that the MBL-PA in Switzerland could be attributed to the wide dissemination of high-risk clones that accounted for most isolates in this study. Although FDC resistance was only found in 8 isolates, MBL carriage was shown to be a major contributor to this phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsHumansSwitzerlandbeta-LactamasesAnti-Bacterial AgentsCarbapenemsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Pseudomonas aeruginosaCarbapenemsEpidemiologyMetallo-beta-lactamase

Substanzen

beta-LactamasesAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, CH-1700, Fribourg, Switzerland. Jacqueline.findlay@unifr.ch.
  • Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, CH-1700, Fribourg, Switzerland.
  • Swiss National Reference Center for Emerging Antibiotic Resistance (NARA) Network, Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.

Förderung

  • University of Fribourg

Zitieren

APA

Findlay, J., Raro, O. H. F., Poirel, L., Nordmann, P., & NARA Network (2024). Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022–2023. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04752-8

Vancouver

Findlay J, Raro OHF, Poirel L, Nordmann P, NARA Network. Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022–2023. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04752-8

BibTeX
@article{Findlay2024,
  author = {Findlay, Jacqueline and Raro, Otavio Hallal Ferreira and Poirel, Laurent and Nordmann, Patrice and NARA Network, NARA Network},
  title = {Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022–2023},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04752-8}
}
Kostenlos starten →